HOME >> MEDICINE >> NEWS
Concerns about fertility affect treatment decisions in one-third of young breast cancer patients

Alexandria, VA--A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients. The study the largest to date to examine fertility concerns among young women with breast cancer found that the majority of the women were very concerned about the ability to have a child as well as the impact that pregnancy might have on disease recurrence, despite the relative lack of data on these risks. The study will be published in the October 15 issue of the Journal of Clinical Oncology.

"These findings indicate that women may overestimate infertility risk, and highlight the need for enhanced communication between physicians and patients," said Ann H. Partridge, MD, MPH, Medical Oncologist at Dana-Farber Cancer Institute, Instructor in Medicine at Harvard Medical School, and lead author of the study. "A key challenge in discussing these issues is the lack of comprehensive data on how cancer therapy affects fertility, particularly when considering newer chemotherapy regimens, and whether getting pregnant after therapy affects the risk of disease recurrence."

Over 11,500 women under the age of 40 are diagnosed with breast cancer each year in the United States. Some breast cancer therapies may cause women to stop menstruating, either temporarily or permanently, and women who continue to have normal menstrual cycles may go through menopause earlier or may be less fertile following chemotherapy than their peers. In addition, while standard hormone-based cancer therapies do not typically cause permanent infertility, they often require years of treatment during which women are advised not to become pregnant.

Researchers surveyed 657 members of the Young Survival Coalition (YSC), a breast cancer patient advocacy group, on their attitudes about fertility. Members were required to be premenopausal and age 40 years or younger at the time of breast cancer diagnosis.
'"/>

Contact: Carrie Housman
housmanc@asco.org
703-519-1423
American Society of Clinical Oncology
12-Oct-2004


Page: 1 2

Related medicine news :

1. Concerns over the future of childrens health care in British general practice
2. Concerns over the value of animal experiments
3. Concerns over national policy on infertility treatment
4. Opponents of needle-exchange programs should think about their message to drug users
5. US life expectancy about to decline, researchers say
6. Most hospital executives have substantial concerns about mandatory error reporting systems
7. Rhesus monkeys reason about perspectives of others in obtaining food
8. Antimicrobials to prevent infection in major surgery are used properly only about half the time
9. Risk factors affect parents attitudes about STD vaccinations
10. Parents have complex opinions about notification laws for minors access to contraception
11. Article highlights confusion about Homeland Security safety symbols

Post Your Comments:
(Date:6/19/2013)... (PRWEB) June 19, 2013 Guests at the ... wealthy and wise even if they don’t go to bed ... require some early thought. , Crafty travelers ... they take advantage of the pet-friendly Scottsdale Paradise Valley hotel’s ... . With at least 14 days advance notice, guests can ...
(Date:6/19/2013)... 19, 2013 At a Travel Services Member ... and growth that has occurred over the last year since ... Shuman said, "Travel Services has added vendors, lowered prices of ... Membership is up, even in the tough economy, and ... of members." , Having been in the Travel Business and ...
(Date:6/19/2013)... June 19, 2013 Amerinet, Inc, ... ARAMARK Healthcare Technologies to help Pacific Medical Centers ... savings of more than 17 percent over the ... expenditures. , “Driving economies of scale and process ... management challenges facing multi-site providers,” said Shawn Padilla, ...
(Date:6/19/2013)... The motor neuron disease Amyotrophic lateral sclerosis (ALS), also ... sequential pattern which can be classified into four distinct ... at the University of Pennsylvania in the Annals ... and spinal cord tissues shows, for the first time, ... starting point in the central nervous system to other ...
(Date:6/19/2013)... pushed to the brink of extinction but can we ... questions which a Bristol academic addresses in his new book, ... at the University of Bristol, has produced the first comprehensive ... the story of polio explores the experiences of victims alongside ... disease. , According to a review by ...
Breaking Medicine News(10 mins):Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Paralysed with fear: The story of polio 2
(Date:6/19/2013)... -- It may seem like an odd pairing: an oral growth ... were two of the most talked about topics at ENDO ... Expo that just convened in San Francisco ... of the top internal medicine experts in the world is ... can not only save lives, but help people feel and ...
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals International, ... (the "Company") announced today that VPII Escrow Corp., a ... has launched its offer of approximately $3.2 billion aggregate ... Notes will be due in 2021 and in 2023, ... Company intends to use the net proceeds from the ...
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals International, ... has priced its previously announced public offering of common ... will issue 23,529,412 common shares at a price of ... $2.0 billion. The Company will file a final prospectus ... S-3 and will make a similar filing with the ...
Breaking Medicine Technology:"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
Cached News: